Paris, France and Boston, MA, USA - January 7, 2016Enterome Bioscience SA (Enterome"), a pioneer in the development of therapeutic solutions based on the gut microbiome, announces that it has entered into a collaborative research agreement with Janssen Biotech, Inc. (Janssen Biotech), one of the Janssen Pharmaceutical Companies ofJohnson & Johnson, and the French National Institute for...
Osaka, Japan, Paris, France and Boston, MA, USA, January 6, 2016 - Takeda Pharmaceutical Company Ltd. (TSE: 4502) and Enterome Bioscience SA (Enterome") today announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including inflammatory...
OXFORD, UK - 7 January 2016 - PsiOxus Therapeutics Ltd. (PsiOxus"), the immuno-oncology company, has appointed Dr Paolo Paoletti, MD as Chairman of the Board."
Cambridge, UK - 5th January 2016: Acacia Pharma Group plc (Acacia Pharma"), the supportive care company developing products for US and international markets, announces positive results from a Phase 3 study investigating BAREMSIST (amisulpride injection, formerly APD421) in combination with standard antiemetics for the prevention of post-operative nausea & vomiting ("PONV") in high-risk patients. "
GAITHERSBURG, Md., Jan. 6, 2016 /PRNewswire/ -- Vtesse, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently...
Two separate studies confirm efficacy of CERAMENTT'G, an antibiotic eluting bone substitute, as a new option in the surgical management of osteomyelitis in the infected diabetic foot.
1 8 9 10


Syv forskningsinstitutioner får 20 mio. kr. til corona-forskning
1. april 2020
Sådan håndterer vi ændring af forskningsprojekter under corona-pandemien
31. marts 2020
Første Corona-bevilling fra Lundbeckfonden til forsøg med et kendt lægemiddel
26. marts 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge